Anterix (ATEX) Cash & Equivalents (2013 - 2026)

Anterix's Cash & Equivalents history runs 14 years deep, the most recent figure standing at $98.5 million for Q1 2026.

• Quarterly Cash & Equivalents rose 107.99% year-over-year to $98.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.5 million (up 107.99% YoY) and the FY2026 annual result came in at $98.5 million, up 107.99% from the prior year.
• Cash & Equivalents was $98.5 million for Q1 2026 at Anterix, up from $29.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $105.6 million in Q1 2022 and bottomed at $28.8 million in Q4 2024.
• A 5-year average of $55.4 million and a median of $48.5 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents sank 66.42% — and 2026, when it surged 107.99%.
• Anterix's Cash & Equivalents stood at $57.5 million in 2022, then increased by 7.86% to $62.0 million in 2023, then slumped by 53.58% to $28.8 million in 2024, then grew by 2.56% to $29.5 million in 2025, then jumped by 233.63% to $98.5 million in 2026.
• Business Quant data shows ATEX's Cash & Equivalents at $98.5 million in Q1 2026, $29.5 million in Q4 2025, and $39.1 million in Q3 2025.